Therapy Areas: Respiratory
Immedica gets UAE approval for Zepzelca maintenance treatment
28 November 2025 - Swedish pharmaceutical company Immedica Pharma AB said on Friday that the Zepzelca (lurbinectedin) + Tecentriq (atezolizumab) maintenance regimen is now approved by the Emirates Dru...
AstraZeneca wins US approval for Imfinzi as first perioperative immunotherapy in early gastric and GEJ cancer
26 November 2025 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Wednesday that it has secured US approval for Imfinzi as the first perioperative immunothe...
AstraZeneca to invest USD2bn in major Maryland manufacturing expansion
24 November 2025 - AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) declared on Monday that it will invest USD2bn to expand its manufacturing footprint in Maryland, adding capacity at its Frederick...
Flagship Pioneering announces new agreements with ProFound Therapeutics and Quotient Therapeutics under GSK collaboration
21 November 2025 - Flagship Pioneering, a scientific innovation engine for transformative platforms and products, announced on Thursday that ProFound Therapeutics and Quotient Therapeutics have entere...
Nuvalent's zidesamtinib NDA filing accepted by US FDA
20 November 2025 - Clinical-stage biopharmaceutical company Nuvalent Inc (Nasdaq:NUVL) said on Wednesday that the US Food and Drug Administration (FDA) has accepted for filing its New Drug Application...
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
19 November 2025 - BioNet, a biotechnology company developing and manufacturing next generation vaccines including recombinant and mRNA vaccines, announced on Tuesday that it has received positive opi...